James R Anderson

James R Anderson,

Dental Radiographer

Department: DN-RADIOLOGY
Business Phone: (352) 273-6664
Business Email: janderson@dental.ufl.edu

Publications

2018
Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children’s Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 36(27):2770-2777 [DOI] 10.1200/JCO.2018.77.9694. [PMID] 30091945.
2018
Impact of Surveillance Imaging Modality on Survival After Recurrence in Patients With Favorable-Histology Wilms Tumor: A Report From the Children’s Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. [DOI] 10.1200/JCO.18.00076. [PMID] 30335557.
2018
Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children’s Oncology Group Study AREN0532.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 36(3):254-261 [DOI] 10.1200/JCO.2017.73.7999. [PMID] 29211618.
2018
Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children’s Oncology Group AREN0533 Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 36(16):1564-1570 [DOI] 10.1200/JCO.2017.77.1931. [PMID] 29659330.
2017
Clinical Outcome and Biological Predictors of Relapse After Nephrectomy Only for Very Low-risk Wilms Tumor: A Report From Children’s Oncology Group AREN0532.
Annals of surgery. 265(4):835-840 [DOI] 10.1097/SLA.0000000000001716. [PMID] 27811504.
2017
Histology, fusion status, and outcome in metastatic rhabdomyosarcoma: A report from the Children’s Oncology Group.
Pediatric blood & cancer. 64(12) [DOI] 10.1002/pbc.26645. [PMID] 28521080.
2017
Patterns of chemotherapy-induced toxicities and outcome in children and adolescents with metastatic rhabdomyosarcoma: A report from the Children’s Oncology Group.
Pediatric blood & cancer. 64(9) [DOI] 10.1002/pbc.26479. [PMID] 28333415.
2017
Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group.
Cancer. 123(12):2368-2375 [DOI] 10.1002/cncr.30613. [PMID] 28211936.
2016
Histology, Fusion Status, and Outcome in Alveolar Rhabdomyosarcoma With Low-Risk Clinical Features: A Report From the Children’s Oncology Group.
Pediatric blood & cancer. 63(4):634-9 [DOI] 10.1002/pbc.25862. [PMID] 26756883.
2016
Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children’s Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 34(2):117-22 [DOI] 10.1200/JCO.2015.63.4048. [PMID] 26503200.
2015
Clinical Application of Prognostic Gene Expression Signature in Fusion Gene-Negative Rhabdomyosarcoma: A Report from the Children’s Oncology Group.
Clinical cancer research : an official journal of the American Association for Cancer Research. 21(20):4733-9 [DOI] 10.1158/1078-0432.CCR-14-3326. [PMID] 26473193.
2015
Impact of persistent minimal residual disease post-consolidation therapy in children and adolescents with advanced Burkitt leukaemia: a Children’s Oncology Group Pilot Study Report.
British journal of haematology. 170(3):367-71 [DOI] 10.1111/bjh.13443. [PMID] 25858645.
2015
Local Control for Intermediate-Risk Rhabdomyosarcoma: Results From D9803 According to Histology, Group, Site, and Size: A Report From the Children’s Oncology Group.
International journal of radiation oncology, biology, physics. 93(5):1071-6 [DOI] 10.1016/j.ijrobp.2015.08.040. [PMID] 26581144.
2015
Prognostic Factors for Outcome in Localized Extremity Rhabdomyosarcoma. Pooled Analysis from Four International Cooperative Groups.
Pediatric blood & cancer. 62(12):2125-31 [DOI] 10.1002/pbc.25684. [PMID] 26257045.
2015
The World Health Organization Classification of Skeletal Muscle Tumors in Pediatric Rhabdomyosarcoma: A Report From the Children’s Oncology Group.
Archives of pathology & laboratory medicine. 139(10):1281-7 [DOI] 10.5858/arpa.2014-0475-OA. [PMID] 25989287.
2014
Aberrant activation, nuclear localization, and phosphorylation of Yes-associated protein-1 in the embryonic kidney and Wilms tumor.
Pediatric blood & cancer. 61(2):198-205 [DOI] 10.1002/pbc.24788. [PMID] 24115727.
2014
Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors.
Cancer discovery. 4(2):216-31 [DOI] 10.1158/2159-8290.CD-13-0639. [PMID] 24436047.
2014
Early response as assessed by anatomic imaging does not predict failure-free survival among patients with Group III rhabdomyosarcoma: a report from the Children’s Oncology Group.
European journal of cancer (Oxford, England : 1990). 50(4):816-23 [DOI] 10.1016/j.ejca.2013.11.031. [PMID] 24361229.
2014
Imaging features of alveolar soft-part sarcoma: a report from Children’s Oncology Group Study ARST0332.
AJR. American journal of roentgenology. 203(6):1345-52 [DOI] 10.2214/AJR.14.12462. [PMID] 25415714.
2014
Myogenin, AP2β, NOS-1, and HMGA2 are surrogate markers of fusion status in rhabdomyosarcoma: a report from the soft tissue sarcoma committee of the children’s oncology group.
The American journal of surgical pathology. 38(5):654-9 [DOI] 10.1097/PAS.0000000000000195. [PMID] 24618610.
2014
Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children’s Oncology Group Report.
British journal of haematology. 167(3):394-401 [DOI] 10.1111/bjh.13040. [PMID] 25066629.
2014
Shorter-duration therapy using vincristine, dactinomycin, and lower-dose cyclophosphamide with or without radiotherapy for patients with newly diagnosed low-risk rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(31):3547-52 [DOI] 10.1200/JCO.2014.55.6787. [PMID] 25267746.
2014
The AII amacrine cell connectome: a dense network hub.
Frontiers in neural circuits. 8 [DOI] 10.3389/fncir.2014.00104. [PMID] 25237297.
2014
TP53 mutational status is a potential marker for risk stratification in Wilms tumour with diffuse anaplasia.
PloS one. 9(10) [DOI] 10.1371/journal.pone.0109924. [PMID] 25313908.
2013
A novel algorithm for simplification of complex gene classifiers in cancer.
Cancer research. 73(18):5625-32 [DOI] 10.1158/0008-5472.CAN-13-0324. [PMID] 23913937.
2013
B7-h1 as a biomarker for therapy failure in patients with favorable histology Wilms tumor.
The Journal of urology. 189(4):1487-92 [DOI] 10.1016/j.juro.2012.11.012. [PMID] 23154206.
2013
Children’s Oncology Group’s 2013 blueprint for research: renal tumors.
Pediatric blood & cancer. 60(6):994-1000 [DOI] 10.1002/pbc.24419. [PMID] 23255438.
2013
Clinicopathologic findings predictive of relapse in children with stage III favorable-histology Wilms tumor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(9):1196-201 [DOI] 10.1200/JCO.2011.41.1165. [PMID] 23382471.
2013
Considerations in the design of clinical trials for pediatric acute lymphoblastic leukemia.
Clinical investigation. 3(9) [DOI] 10.4155/cli.13.71. [PMID] 24273641.
2013
Dense pattern of embryonal rhabdomyosarcoma, a lesion easily confused with alveolar rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group.
American journal of clinical pathology. 140(1):82-90 [DOI] 10.1309/AJCPA1WN7ARPCMKQ. [PMID] 23765537.
2013
Gain of 1q is associated with inferior event-free and overall survival in patients with favorable histology Wilms tumor: a report from the Children’s Oncology Group.
Cancer. 119(21):3887-94 [DOI] 10.1002/cncr.28239. [PMID] 23983061.
2013
Histologic and clinical characteristics can guide staging evaluations for children and adolescents with rhabdomyosarcoma: a report from the Children’s Oncology Group Soft Tissue Sarcoma Committee.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(26):3226-32 [DOI] 10.1200/JCO.2012.44.6476. [PMID] 23940218.
2013
Is adrenalectomy necessary during unilateral nephrectomy for Wilms Tumor? A report from the Children’s Oncology Group.
Journal of pediatric surgery. 48(7):1598-603 [DOI] 10.1016/j.jpedsurg.2013.04.019. [PMID] 23895979.
2013
ON cone bipolar cell axonal synapses in the OFF inner plexiform layer of the rabbit retina.
The Journal of comparative neurology. 521(5):977-1000 [DOI] 10.1002/cne.23244. [PMID] 23042441.
2013
Retinal connectomics: towards complete, accurate networks.
Progress in retinal and eye research. 37:141-62 [DOI] 10.1016/j.preteyeres.2013.08.002. [PMID] 24016532.
2013
Safety and efficacy of high-dose tamoxifen and sulindac for desmoid tumor in children: results of a Children’s Oncology Group (COG) phase II study.
Pediatric blood & cancer. 60(7):1108-12 [DOI] 10.1002/pbc.24457. [PMID] 23281268.
2013
Stress-induced isoforms of MDM2 and MDM4 correlate with high-grade disease and an altered splicing network in pediatric rhabdomyosarcoma.
Neoplasia (New York, N.Y.). 15(9):1049-63 [PMID] 24027430.
View on: PubMed
2013
Susceptibility of enterococci to daptomycin is dependent upon testing methodology.
Diagnostic microbiology and infectious disease. 76(4):497-501 [DOI] 10.1016/j.diagmicrobio.2013.04.019. [PMID] 23719086.
2013
The effect of radiation timing on patients with high-risk features of parameningeal rhabdomyosarcoma: an analysis of IRS-IV and D9803.
International journal of radiation oncology, biology, physics. 87(3):512-6 [DOI] 10.1016/j.ijrobp.2013.07.003. [PMID] 24074925.
2012
Building retinal connectomes.
Current opinion in neurobiology. 22(4):568-74 [DOI] 10.1016/j.conb.2012.03.011. [PMID] 22498714.
2012
Clinical significance of pulmonary nodules detected by CT and Not CXR in patients treated for favorable histology Wilms tumor on national Wilms tumor studies-4 and -5: a report from the Children’s Oncology Group.
Pediatric blood & cancer. 59(4):631-5 [DOI] 10.1002/pbc.24123. [PMID] 22422736.
2012
Effect of hospital-wide chlorhexidine patient bathing on healthcare-associated infections.
Infection control and hospital epidemiology. 33(11):1094-100 [DOI] 10.1086/668024. [PMID] 23041806.
2012
Effect of radiotherapy techniques (IMRT vs. 3D-CRT) on outcome in patients with intermediate-risk rhabdomyosarcoma enrolled in COG D9803–a report from the Children’s Oncology Group.
International journal of radiation oncology, biology, physics. 82(5):1764-70 [DOI] 10.1016/j.ijrobp.2011.01.036. [PMID] 21470795.
2012
Evaluation of diagnostic performance of CT for detection of tumor thrombus in children with Wilms tumor: a report from the Children’s Oncology Group.
Pediatric blood & cancer. 58(4):551-5 [DOI] 10.1002/pbc.23222. [PMID] 21674767.
2012
Lymph node involvement in Wilms tumor: results from National Wilms Tumor Studies 4 and 5.
Journal of pediatric surgery. 47(4):700-6 [DOI] 10.1016/j.jpedsurg.2011.08.017. [PMID] 22498384.
2012
Patterns of chemotherapy-induced toxicities in younger children and adolescents with rhabdomyosarcoma: a report from the Children’s Oncology Group Soft Tissue Sarcoma Committee.
Cancer. 118(4):1130-7 [DOI] 10.1002/cncr.26358. [PMID] 21761400.
2012
SIX2 and CITED1, markers of nephronic progenitor self-renewal, remain active in primitive elements of Wilms’ tumor.
Journal of pediatric surgery. 47(6):1239-49 [DOI] 10.1016/j.jpedsurg.2012.03.034. [PMID] 22703800.
2011
Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder/prostate: combined results from the Children’s Oncology Group, German Cooperative Soft Tissue Sarcoma Study, Italian Cooperative Group, and International Society of Pediatric Oncology Malignant Mesenchymal Tumors Committee.
International journal of cancer. 128(5):1232-9 [DOI] 10.1002/ijc.25444. [PMID] 20473932.
2011
Exploring the retinal connectome.
Molecular vision. 17:355-79 [PMID] 21311605.
View on: PubMed
2011
Hedgehog pathway activity in pediatric embryonal rhabdomyosarcoma and undifferentiated sarcoma: a report from the Children’s Oncology Group.
Pediatric blood & cancer. 57(6):930-8 [DOI] 10.1002/pbc.23174. [PMID] 21618411.
2011
Molecular profiling reveals frequent gain of MYCN and anaplasia-specific loss of 4q and 14q in Wilms tumor.
Genes, chromosomes & cancer. 50(12):982-95 [DOI] 10.1002/gcc.20907. [PMID] 21882282.
2011
Regional nodal involvement and patterns of spread along in-transit pathways in children with rhabdomyosarcoma of the extremity: a report from the Children’s Oncology Group.
International journal of radiation oncology, biology, physics. 80(4):1151-7 [DOI] 10.1016/j.ijrobp.2010.03.050. [PMID] 20542386.
2011
Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(10):1312-8 [DOI] 10.1200/JCO.2010.30.4469. [PMID] 21357783.
2011
Rhabdomyosarcoma in infants younger than 1 year: a report from the Children’s Oncology Group.
Cancer. 117(15):3493-501 [DOI] 10.1002/cncr.25887. [PMID] 21264837.
2011
The Children’s Oncology Group routinely applies “lack of efficacy” interim monitoring to its randomized clinical trials.
The American journal of bioethics : AJOB. 11(3):18-9 [DOI] 10.1080/15265161.2011.552357. [PMID] 21400379.
2011
The management of synchronous bilateral Wilms tumor: a report from the National Wilms Tumor Study Group.
Annals of surgery. 253(5):1004-10 [DOI] 10.1097/SLA.0b013e31821266a0. [PMID] 21394016.
2011
WT1 mutation and 11P15 loss of heterozygosity predict relapse in very low-risk wilms tumors treated with surgery alone: a children’s oncology group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(6):698-703 [DOI] 10.1200/JCO.2010.31.5192. [PMID] 21189373.
2010
Detection of neuron membranes in electron microscopy images using a serial neural network architecture.
Medical image analysis. 14(6):770-83 [DOI] 10.1016/j.media.2010.06.002. [PMID] 20598935.
2010
Early treatment failure in intermediate-risk rhabdomyosarcoma: results from IRS-IV and D9803–a report from the Children’s Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(27):4228-32 [DOI] 10.1200/JCO.2010.29.0247. [PMID] 20713850.
2010
Fusion-negative alveolar rhabdomyosarcoma: modification of risk stratification is premature.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(29):e587-8; author reply e589 [DOI] 10.1200/JCO.2010.30.5466. [PMID] 20697086.
2010
Gene expression profiling for survival prediction in pediatric rhabdomyosarcomas: a report from the children’s oncology group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(7):1240-6 [DOI] 10.1200/JCO.2008.21.1268. [PMID] 20124188.
2010
Grading of nonrhabdomyosarcoma soft tissue sarcoma in children and adolescents: a comparison of parameters used for the Fédération Nationale des Centers de Lutte Contre le Cancer and Pediatric Oncology Group Systems.
Cancer. 116(9):2266-74 [DOI] 10.1002/cncr.24929. [PMID] 20166208.
2010
Long-term outcomes for infants with very low risk Wilms tumor treated with surgery alone in National Wilms Tumor Study-5.
Annals of surgery. 251(3):555-8 [DOI] 10.1097/SLA.0b013e3181c0e5d7. [PMID] 20142733.
2010
Orbital sarcoma with metastases at diagnosis: a report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group.
Pediatric blood & cancer. 54(7):1045-7 [DOI] 10.1002/pbc.22434. [PMID] 20162686.
2010
Outcomes of children with favorable histology wilms tumor and peritoneal implants treated in National Wilms Tumor Studies-4 and -5.
International journal of radiation oncology, biology, physics. 77(2):554-8 [DOI] 10.1016/j.ijrobp.2009.04.081. [PMID] 20457352.
2010
Public-academic partnerships: working together to meet the needs of Army National Guard soldiers: an academic-military partnership.
Psychiatric services (Washington, D.C.). 61(11):1069-71 [DOI] 10.1176/ps.2010.61.11.1069. [PMID] 21041342.
2010
Randomized phase II window trial of two schedules of irinotecan with vincristine in patients with first relapse or progression of rhabdomyosarcoma: a report from the Children’s Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(30):4658-63 [DOI] 10.1200/JCO.2010.29.7390. [PMID] 20837952.
2010
The use of central laboratories and remote electronic data capture to risk-adjust therapy for pediatric acute lymphoblastic leukemia and neuroblastoma.
Seminars in oncology. 37(1):53-9 [DOI] 10.1053/j.seminoncol.2009.12.007. [PMID] 20172365.
2010
Treatment results for patients with localized, completely resected (Group I) alveolar rhabdomyosarcoma on Intergroup Rhabdomyosarcoma Study Group (IRSG) protocols III and IV, 1984-1997: a report from the Children’s Oncology Group.
Pediatric blood & cancer. 55(4):612-6 [DOI] 10.1002/pbc.22520. [PMID] 20806360.
2009
Hepatic metastasis at diagnosis in patients with Wilms tumor is not an independent adverse prognostic factor for stage IV Wilms tumor: a report from the Children’s Oncology Group/National Wilms Tumor Study Group.
Annals of surgery. 250(4):642-8 [DOI] 10.1097/SLA.0b013e3181b76f20. [PMID] 19730241.
2009
Problems identified with phase II stopping rules that employ response and early-progression rates.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(4):646-7; author reply 647 [DOI] 10.1200/JCO.2008.19.9182. [PMID] 19103727.
2009
Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children’s oncology group study D9803.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(31):5182-8 [DOI] 10.1200/JCO.2009.22.3768. [PMID] 19770373.
2008
Analysis of survival by tumor response and other comparisons of time-to-event by outcome variables.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(24):3913-5 [DOI] 10.1200/JCO.2008.16.1000. [PMID] 18711176.
2008
Comparison of results of a pilot study of alternating vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide with IRS-IV in intermediate risk rhabdomyosarcoma: a report from the Children’s Oncology Group.
Pediatric blood & cancer. 50(1):33-6 [PMID] 17091486.
View on: PubMed
2008
Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(14):2384-9 [DOI] 10.1200/JCO.2007.14.7207. [PMID] 18467730.
2008
Progress in childhood cancer: 50 years of research collaboration, a report from the Children’s Oncology Group.
Seminars in oncology. 35(5):484-93 [DOI] 10.1053/j.seminoncol.2008.07.008. [PMID] 18929147.
2008
The impact of surgical excision in chest wall rhabdomyosarcoma: a report from the Children’s Oncology Group.
Journal of pediatric surgery. 43(5):831-6 [DOI] 10.1016/j.jpedsurg.2007.12.021. [PMID] 18485948.
2007
Assessment of response to induction therapy and its influence on 5-year failure-free survival in group III rhabdomyosarcoma: the Intergroup Rhabdomyosarcoma Study-IV experience–a report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(31):4909-13 [PMID] 17971587.
View on: PubMed
2007
Specific extra chromosomes occur in a modal number dependent pattern in pediatric acute lymphoblastic leukemia.
Genes, chromosomes & cancer. 46(7):684-93 [PMID] 17431878.
View on: PubMed
2006
Patient consent in the era of de-identified research databases.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 24(4):720-1 [PMID] 16446347.
View on: PubMed
2006
Pooled analysis of phase II window studies in children with contemporary high-risk metastatic rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 24(21):3415-22 [PMID] 16849756.
View on: PubMed
2005
Analysis of outcome by response flawed.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 23(31):8122-3; author reply 8123 [PMID] 16258114.
View on: PubMed
2005
Association of NAT and GST polymorphisms with non-Hodgkin’s lymphoma: a population-based case-control study.
British journal of haematology. 128(5):610-5 [PMID] 15725081.
View on: PubMed
2005
Rhabdomyosarcoma: many similarities, a few philosophical differences.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 23(12):2586-7 [PMID] 15728222.
View on: PubMed
2004
Age is an independent prognostic factor in rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group.
Pediatric blood & cancer. 42(1):64-73 [PMID] 14752797.
View on: PubMed
2004
Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: a report from the soft tissue sarcoma committee of the children’s oncology group.
Clinical cancer research : an official journal of the American Association for Cancer Research. 10(18 Pt 1):6072-9 [PMID] 15447992.
View on: PubMed
2004
Favorable outcome for children with paratesticular alveolar history rhabdomysosarcoma.
Pediatric blood & cancer. 43(2) [PMID] 15236289.
View on: PubMed
2004
Late events occurring five years or more after successful therapy for childhood rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group.
European journal of cancer (Oxford, England : 1990). 40(12):1878-85 [PMID] 15288290.
View on: PubMed
2004
Neurofibromatosis in children with Rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma study IV.
The Journal of pediatrics. 144(5):666-8 [PMID] 15127010.
View on: PubMed
2003
Burkitt’s and Burkitt-like lymphoma in children and adolescents: a review of the Children’s Cancer Group experience.
British journal of haematology. 120(4):660-70 [PMID] 12588354.
View on: PubMed
2003
Childhood and adolescent large-cell lymphoma (LCL): a review of the Children’s Cancer Group experience.
American journal of hematology. 72(1):53-63 [PMID] 12508269.
View on: PubMed
2003
Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma–a report from the Intergroup Rhabdomyosarcoma Study IV.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 21(1):78-84 [PMID] 12506174.
View on: PubMed
2003
Prognostic factors and surgical treatment guidelines for children with rhabdomyosarcoma of the perineum or anus: a report of Intergroup Rhabdomyosarcoma Studies I through IV, 1972 through 1997.
Journal of pediatric surgery. 38(3):347-53 [PMID] 12632347.
View on: PubMed
2002
Children from ethnic minorities have benefited equally as other children from contemporary therapy for rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20(22):4428-33 [PMID] 12431964.
View on: PubMed
2002
Cytodifferentiation and clinical outcome after chemotherapy and radiation therapy for rhabdomyosarcoma (RMS).
Medical and pediatric oncology. 38(6):398-404 [PMID] 11984800.
View on: PubMed
2002
Treatment of children and adolescents with localized parameningeal sarcoma: experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through -IV, 1978-1997.
Medical and pediatric oncology. 38(1):22-32 [PMID] 11835233.
View on: PubMed

Contact Details

Phones:
Business:
(352) 273-6664
Emails: